News Aptar buys digital health partner Healint More evidence of consolidation in the digital health category has come with the news that Aptar has bought Singapore’s Healint, which develops patient support apps as well
R&D Importance of diversity in pharma and clinical trials “Diversity.” It’s a word that is very commonly thrown around right now, not just in pharma and healthcare but across all industries.
R&D Assumptions to evidence: How NIHR project is solidifying UK’... Remote, virtual, or decentralised clinical trials are nothing new, but COVID-19 catapulted the model into the mainstream.
News FDA experts lukewarm on AZ's anticoagulant antidote Andexxa AstraZeneca is facing some pushback as it tries to upgrade anticoagulant antidote drug Andexaa to full approval in the US
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends